Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors.


Creative Commons License

Erfan G., Puig S., Carrera C., Arance A., Gaba L., Victoria I., ...Daha Fazla

Acta dermato-venereologica, cilt.97, sa.2, ss.258-260, 2017 (SCI-Expanded) identifier identifier identifier